Solugen
Decarbonizing the chemicals industry.
Houston, United States · Founded 2017 · $645.7M raised
- Headquarters
- Houston, Texas
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- solugen.com
- Total Funding
- $645.7M
- Last Round
- $20.0M Venture RoundMar 2026
- Rounds
- 7
About
Solugen is decarbonizing the chemistry of everyday life with enzymes and innovative metal catalysts. Our new to the world Bioforge platform technology can produce high value chemical goods that are biobased and carbon negative, at cost on par with current technologies. We are making sustainable chemistry accessible to all living things, to ensure a prosperous world exists for generations.
Summary
Solugen is a Biotech company based in Houston, United States, founded in 2017. It has raised $645.7M in total across 7 rounds, most recently a $20.0M Venture Round round in Mar 2026. Investors include Refactor Capital, Fifty Years and Baillie Gifford.
Tech & App Stack
9 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Sign up to see all 7 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Refactor Capital
5 rounds
Fifty Years
4 rounds
Baillie Gifford
2 rounds
Canada Growth Fund
1 round
Kinnevik
1 round
Lowercarbon Capital
1 round
GIC
1 round
Founders Fund
1 round
Y Combinator Continuity Fund
3 rounds
Temasek
2 rounds
KdT Ventures
2 rounds
BlackRock
1 round
Carbon Direct Capital Management
1 round
Liquid 2 Ventures
1 round
Social Capital
1 round
Similar Companies
Green steel company using hydrogen and renewable electricity to decarbonize steel production. For...
Self-driving cars.
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company